PTX-022
PALV-12
Phase 2 small_molecule active
Quick answer
PTX-022 for Angiokeratomas is a Phase 2 program (small_molecule) at PALVELLA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PALVELLA THERAPEUTICS, INC.
- Indication
- Angiokeratomas
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active